Abstract
Histone proteins that form the nucleosome core are subject to a variety of post-translational transformations. These histone modifications make up the histone code which extends the information in the genetic code and is emerging as an essential mechanism to regulate gene expression. In spite of a current flurry of significant advances in experimental studies, there has been little theoretical understanding regarding how enzymes generate or remove these modifications. Very recently, we have made excellent progresses in investigating two such important histone-modifying enzyme families: zinc-dependent histone deacetylases (HDACs) and histone lysine methyltransferases (HKMTs). Our studies on a histonedeacetylase- like protein HDLP suggested a novel catalytic mechanism. The simulations on HKMT SET7/9 have characterized the histone lysine methylation reaction and elucidated the origin of enzyme catalysis. Our computational approaches centered on the pseudobond ab initio quantum mechanical/molecular mechanical (QM/MM) method, which allows for accurate modeling of the chemistry at the reaction active site while properly including the effects of the protein environment
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41–45
Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074–1080
Iizuka M, Smith MM (2003) Functional consequences of histone modifications. Curr Opin Genet Dev 13:154–160
Khorasanizadeh S (2004) The nucleosome: from genomic organization to genomic regulation. Cell 116:259–272
Khan AU, Krishnamurthy S (2005) Histone modifications as key regulators of transcription. Front Biosci 10:866–872
Biel M, Wascholowski V, Giannis A (2005) Epigenetics – an epicenter of gene regulation: histones and histone-modifying enzymes. Angew Chem-Int Edit 44:3186–3216
Turner BM (2002) Cellular memory and the histone code. Cell 111:285–291
Fischle W, Wang YM, Allis CD (2003) Binary switches and modification cassettes in histone biology and beyond. Nature 425:475–479
Margueron R, Trojer P, Reinberg D (2005) The key to development: interpreting the histone code? Curr Opin Genet Dev 15:163–176
Hake SB, Xiao A, Allis CD (2004) Linking the epigenetic ‘language’ of covalent histone modifications to cancer. Br J Cancer 90:761–769
Santos-rosa H, Caldas C (2005) Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41:2381–2402
Warshel A, Levitt M (1976) Theoretic studies of enzymic reactions: dielectric electrostatic and steric stabilization if the carbonium ion in the reaction of lysozyme. J Mol Bio 103:227
Singh UC, Kollman PA (1986) A combined ab initio quantum mechanical and molecular mechanical method for carrying out simulations on complex molecular systems: applications to the ch_3 cl+ cl – exchange reaction and gas phase protonation of polyethers. J Comp Chem 7:718–730
Field MJ, Bash PA, Karplus M (1990) A combined quantum mechanical and molecular mechanical potential for molecular dynamics simulations. J Comp Chem 11:700–733
Gao J, Truhlar DG (2002) Quantum mechanical methods for enzyme kinetics. Annu Rev Phys Chem 53:467–505
Gao JL, Ma SH, Major DT, Nam K, Pu JZ, Truhlar DG (2006) Mechanisms and free energies of enzymatic reactions. Chem Rev 106:3188–3209
Warshel A, Sharma PK, Kato M, Xiang Y, Liu HB, Olsson MHM (2006) Electrostatic basis for enzyme catalysis. Chem Rev 106:3210–3235
Friesner RA, Guallar V (2005) Ab initio quantum chemical and mixed quantum mechanics/molecular mechanics (QM/MM) methods for studying enzymatic catalysis. Annu Rev Phys Chem 56:389–427
Mulholland AJ (2005) Modelling enzyme reaction mechanisms, specificity and catalysis. Drug Discov Today 10:1393–1402
Zhang Y (2006) Pseudobond ab initio QM/MM approach and its applications to enzyme reactions. Theor Chem Acc 116:43–50
Riccardi D, Schaefer P, Yang Y, Yu HB, Ghosh N, Prat-resina X, Konig P, Li GH, Xu DG, Guo H, Elstner M, Cui Q (2006) Development of effective quantum mechanical/molecular mechanical (QM/MM) methods for complex biological processes. J Phys Chem B 110:6458–6469
Bruice TC (2006) Computational approaches: reaction trajectories, structures, and atomic motions: enzyme reactions and proficiency. Chem Rev 106:3119–3139
Hammes-schiffer S (2004) Quantum-classical simulation methods for hydrogen transfer in enzymes: a case study of dihydrofolate reductase. Curr Opin Struct Biol 14:192–201
Garcia-viloca M, Gao J, Karplus M, Truhlar DG (2004) How enzymes work: analysis by modern rate theory and computer simulations. Science 303:186–195
Senn HM, Thiel W (2007) QM/MM methods for biological systems. Top Curr Chem 268:173–290
Zhang Y, Lee TS, Yang W (1999) A pseudobond approach to combining quantum mechanical and molecular mechanical methods. J Chem Phys 110:46–54
Zhang Y, Liu H, Yang W (2000) Free energy calculation on enzyme reactions with an efficient iterative procedure to determine minimum energy paths on a combined ab initio QM/MM potential energy surface. J Chem Phys 112:3483–3492
Zhang Y, Liu H, Yang W (2002) Ab initio QM/MM and free energy calculations of enzyme reactions. In: Schlick T., Gan H. H., (ed) Methods for Macromolecular Modeling. Springer-Verlag; Berlin, pp 332–354
Zhang Y (2005) Improved pseudobonds for combined ab initio quantum mechanical/molecular mechanical methods. J Chem Phys 122:024114
Liu H, Zhang Y, Yang W (2000) How is the active site of enolase organized to catalyze two different reaction steps? J Am Chem Soc 122:6560–6570
Zhang Y, Kua J, McCammon JA (2002) Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM/MM study. J Am Chem Soc 124:10572–10577
Zhang Y, Kua J, McCammon JA (2003) Influence of structural fluctuation on enzyme reaction energy barriers in combined quantum mechanical/molecular mechanical studies. J Phys Chem B 107:4459–4463
Cisneros GA, Liu H, Zhang Y, Yang W (2003) Ab initio QM/MM study shows there is no general acid in the reaction catalyzed by 4-oxalocrotonate tautornerase. J Am Chem Soc 125:10384–10393
Cheng Y, Zhang Y, McCammon JA (2005) How does the camp-dependent protein kinase catalyze the phosphorylation reaction: an ab initio QM/MM study. J Am Chem Soc 127:1553–1562
Cheng Y, Zhang Y, McCammon JA (2006) How does activation loop phosphorylation modulate catalytic activity in the camp-dependent protein kinase: a theoretical study. Protein Sci 15:672–683
Poyner RR, Larsen TM, Wong SW, Reed GH (2002) Functional and structural changes due to a serine to alanine mutation in the active-site flap of enolase. Arch Biochem Biophys 401:155–163
Cisneros GA, Wang M, Silinski P, Fitzgerald MC, Yang WT (2004) The protein backbone makes important contributions to 4-oxalocrotonate tautomerase enzyme catalysis: understanding from theory and experiment. Biochemistry 43:6885–6892
Metanis N, Brik A, Dawson PE, Keinan E (2004) Electrostatic interactions dominate the catalytic contribution of arg39 in 4-oxalocrotonate tautomerase. J Am Chem Soc 126:12726–12727
Corminboeuf C, Hu P, Tuckerman ME, Zhang Y (2006) Unexpected catalytic mechanism for histone deacetylase suggested by a density functional theory QM/MM study. J Am Chem Soc 128:4530–4531
De ruijter AJM, Vangennip AH, Caron HN, Kemp S, Vankuilenburg ABP (2003) Histone deacetylases (hdacs): characterization of the classical hdac family. Biochem J 370:737–749
Holbert MA, Marmorstein R (2005) Structure and activity of enzymes that remove histone modifications. Curr Opin Struct Biol 15:673–680
Gregoretti IV, Lee YM, Goodson HV (2004) Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 338:17–31
Acharya MR, Sparreboom A, Venitz J, Figg WD (2005) Rational development of histone deacetylase inhibitors as anticancer agents: a review. Mol Pharmacol 68:917–932
Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC (2005) Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 45:495–528
Kelly WK, Marks PA (2005) Drug insight: histone deacetylase inhibitors - development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat Clin Pract Oncol 2:150–157
Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK (2001) Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1:194–202
Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP (1999) Structures of a histone deacetylase homologue bound to the tsa and saha inhibitors. Nature 401:188–193
Kapustin GV, Fejer G, Gronlund JL, Mccafferty DG, Seto E, Etzkorn FA (2003) Phosphorus-based saha analogues as histone deacetylase inhibitors. Org Lett 5:3053–3056
Hu P, Zhang Y (2006) Catalytic mechanism and product specificity of the histone lysine methyltransferase set7/9: An ab initio QM/MM-FE study with multiple initial structures. J Am Chem Soc 128:1272–1278
Wang S, Hu P, Zhang Y (2007) Ab initio quantum mechanical/molecular mechanical molecular dynamics simulation of enzyme catalysis: the case of histone lysine methyltransferase set7/9. J Phys Chem B ASAP
Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6:838–849
Schneider R, Bannister AJ, Kouzarides T (2002) Unsafe sets: histone lysine methyltransferases and cancer. Trends Biochem Sci 27:396–402
Xiao B, Wilson JR, Gamblin SJ (2003) Set domains and histone methylation. Curr Opin Struct Biol 13:699–705
Cheng X, Collins RE, Zhang X (2005) Structural and sequence motifs of protein (histone) methylation enzymes. Annu Rev Biophys Biomolec Struct 34:267–294
Min J, Feng Q, Li Z, Zhang Y, Xu R (2003) Structure of the catalytic domain of human dot1l, a non-set domain nucleosomal histone methyltransferase. Cell 112:711–723
Yeates TO (2002) Structures of set domain proteins: protein lysine methyltransferases make their mark. Cell 111:5–7
Wilson JR, Jing C, Walker PA, Martin SR, Howell SA, Blackburn GM, Gamblin SJ, Xiao B (2002) Crystal structure and functional analysis of the histone methyltransferase set7/9. Cell 111:105–115
Xiao B, Jing C, Wilson JR, Walker PA, Vasisht N, Kelly G, Howell S, Taylor IA, Blackburn GM, Gamblin SJ (2003) Structure and catalytic mechanism of the human histone methyltransferase set7/9. Nature 421:652–656
Kwon T, Chang JH, Kwak E, Lee CW, Joachimiak A, Kim YC, Lee JW, Cho Y (2003) Mechanism of histone lysine methyl transfer revealed by the structure of set7/9-adomet. EMBO J., 22:292–303
Trievel RC, Beach BM, Dirk LMA, Houtz RL, Hurley JH (2002) Structure and catalytic mechanism of a set domain protein methyltransferase. Cell 111:91–103
Takusagawa F, Fujioka M, Spies A, Schowen RL (1998) S-adenosylmethionine (adomet)-dependent methyltransferases. In: Sinnott M., (ed), Comprehensive biological catalysis: a mechanistic reference. Academic Press, San Diego, pp 1–30
Mildvan AS (1997) Mechanisms of signaling and related enzymes. Proteins 29:401–416
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Zhang, Y. (2009). Ab Initio Quantum Mechanical/Molecular Mechanical Studies of Histone Modifying Enzymes. In: York, D.M., Lee, TS. (eds) Multi-scale Quantum Models for Biocatalysis. Challenges and Advances in Computational Chemistry and Physics, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9956-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9956-4_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9955-7
Online ISBN: 978-1-4020-9956-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)